Are counterfeit or substandard anti‐infective products the cause of treatment failure in Papua New Guinea?
A Nair, S Strauch, J Lauwo… - Journal of …, 2011 - Wiley Online Library
Counterfeit and substandard products present a big challenge to any national plan or policy
devised to improve public health. Poor quality drug products are especially a problem in …
devised to improve public health. Poor quality drug products are especially a problem in …
Assessment of the incidence of substandard drugs in developing countries
O Shakoor, RB Taylor… - Tropical Medicine & …, 1997 - Wiley Online Library
In a number of developing countries there is reportedly a high incidence of the availability of
substandard drugs. The majonty of these reports do not contain quantitative data to support …
substandard drugs. The majonty of these reports do not contain quantitative data to support …
Counterfeit and substandard anti-infectives in developing countries
PN Newton, FM Fernandez, MD Green… - … resistance in developing …, 2010 - Springer
There is considerable interest in optimizing the therapy for important infections in developing
countries and in making the best treatments readily available and inexpensive. There is also …
countries and in making the best treatments readily available and inexpensive. There is also …
An investigation into the quality of medicines in Yangon, Myanmar
MR Islam, N Yoshida, K Kimura, C Uwatoko… - Pharmacy, 2018 - mdpi.com
Many poor-quality medicines are supplied to patients mainly in developing countries. No
systematic survey on counterfeit medicines has been conducted in Myanmar since 1999 …
systematic survey on counterfeit medicines has been conducted in Myanmar since 1999 …
[PDF][PDF] Cambodian ministry of health takes decisive actions in the fight against substandard and counterfeit medicines
LA Krech, CL Barlow, L Siv… - Tropical Medicine …, 2014 - pdfs.semanticscholar.org
Abstract Cambodia's Ministry of Health and the Department of Drugs and Food have been
actively working to reduce the amount of poor quality medicines circulating in the …
actively working to reduce the amount of poor quality medicines circulating in the …
Etude de la qualite des medicaments vendus et dispenses au Cambodge
F Gimenez, C Bruneton, DYN Rith - Médecine et maladies infectieuses, 1997 - Elsevier
Several articles in the press have reported alarming percentages of counterfeit drugs in
developing countries. The present study assessed the quality of anti-infectious drugs in …
developing countries. The present study assessed the quality of anti-infectious drugs in …
[HTML][HTML] Low prevalence of substandard and falsified antimalarial and antibiotic medicines in public and faith-based health facilities of southern Malawi
F Khuluza, S Kigera, L Heide - The American journal of tropical …, 2017 - ncbi.nlm.nih.gov
Substandard and falsified antimalarial and antibiotic medicines represent a serious problem
for public health, especially in low-and middle-income countries. However, information on …
for public health, especially in low-and middle-income countries. However, information on …
Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania
Objective: There are several independent reports in Tanzania of treatment failures with
commercially available sulphadoxine/pyrimethamine (SP) and amodiaquine (AQ) brands …
commercially available sulphadoxine/pyrimethamine (SP) and amodiaquine (AQ) brands …
[HTML][HTML] Substandard and falsified antibiotics and medicines against noncommunicable diseases in western Cameroon and northeastern Democratic Republic of …
S Schäfermann, C Hauk, E Wemakor… - The American Journal …, 2020 - ncbi.nlm.nih.gov
Falsified and substandard medicines may undermine the progress toward the Sustainable
Development Goals. The present study investigated the quality of 13 essential medicines in …
Development Goals. The present study investigated the quality of 13 essential medicines in …
[HTML][HTML] Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
C Hauk, N Hagen, L Heide - The American Journal of Tropical …, 2021 - ncbi.nlm.nih.gov
Substandard and falsified medicines have severe public health and socioeconomic effects,
especially in low-and middle-income countries. The WHO has emphasized the need for …
especially in low-and middle-income countries. The WHO has emphasized the need for …